Immunisation Upper Age Limits

29 May 2017

It is very important to note there are maximum age limits and general guidelines for many vaccines. Please refer to the below table, referenced throughout from the online Australian Immunisation Handbook 10th edition, for specific details related to each disease.

Disease/VaccineAgeVaccine RecommendationNotes
DTPa <10 years

DTPa-containing vaccines can be used for catch-up of primary or booster doses in children.

i.e. Infanrix, Infanrix Hexa, Infanrix IPV

Monovalent pertussis vaccine is not available in Australia.
>10 years

Boostrix/Adacel/Boostrix/IPV/Adacel Polio must be used for over 10 year old catch ups - see guidelines

Hepatitis B


<20 years 3 dose course of monovalent Hepatitis B vaccine:
paediatric vaccine at 0,1,6 months

See notes below table.

11-15 years only 2 doses of monovalent Hepatitis B adult formulation , 4 months apart see table 2.1.12

>20 years

3 dose course of monovalent Hepatitis B vaccine:
adult vaccine at 0,1,6 months


<14 years

At least 1 dose. If second dose given, a 4-week interval is required

MMRV (Priorix Tetra ) is suitable to provide varicella vaccination in children aged <14 years. This vaccine is not recommended for use in persons ≥14 years of age. (Refer also to 4.22 Varicella.)

>14 years

2 doses 4 weeks apart

Meningococcal C <10 years A single dose of MenCCV-containing vaccine is recommended for children at 12 months of age (as either MenCCV  or the combination vaccine Hib-MenCCV- i.e. Menitorix).

If a dose has not been given at ≥12 months of age (or if dose(s) were given at <12 months of age), a single dose of MenCCV is recommended.

Conjugate meningococcal vaccines: see notes below table.

>10 years NeisVax C is available through the State Vaccine Centre for NIP online ordering, for Meningococcal C catch up for over 10 year olds.
Pneumococcal Conjugate Vaccine – Prevenar 13


<5 years See table 2.1.9


>5 years Children aged ≥5 years who are not at increased risk of invasive pneumococcal disease (including Indigenous children aged ≥5 years) do not require catch-up doses of PCV.


Pneumococcal Polysaccharide Vaccine – Pneumovax 23


Refer to 4.13 Pneumococcal Disease




The recommended number of doses and intervals for Hib vaccines vary with the vaccine type and age of the child. For catch-up recommendations refer to Table 2.1.8.


For extremely preterm and/or low-birth-weight infants (<28 weeks gestation or <1500 g birth weight), 4 doses of a Hib-containing vaccine (irrespective of the brand used) should be given, at 2, 4, 6 and 12 months of age (refer to 3.3.2 Vaccination of women who are planning pregnancy, pregnant or breastfeeding, and preterm infants).




If no previous doses of poliomyelitis vaccine have been given, give 3 doses of IPV or IPV-containing vaccines at least 4 weeks apart (refer to 4.14 Poliomyelitis). (Previous doses of OPV are interchangeable with IPV.)

If the 3rd dose of IPV is administered at ≤3.5 years of age, give the 4th (booster) dose at the 4th birthday. If the 3rd dose is given after 3.5 years, the 4th dose is not required. However, if the use of combination vaccines is necessary, a further IPV-containing dose may be given.




Catch-up rotavirus vaccination of older infants or children is not recommended

It is recommended that vaccine doses are not given beyond the upper age limits specified in Table 4.17.1

2017 Influenza

<6 months

No vaccine

Poster available here




6 months to 35 months (<3 years)

FluQuadri Junior (Sanofi Pasteur)

≥3 to 18 years

FluQuadri (Sanofi Pasteur)

Fluarix Tetra (GSK)

≥18 years

FluQuadri (Sanofi Pasteur)

Fluarix Tetra (GSK)

Afluria Quad (Seqirus)


>50 years

See recommendations


*Hepatitis B

Australian-born infants typically receive a monovalent hepatitis B vaccine dose at birth followed by a 3-dose primary course of hepatitis B-containing vaccine at 2, 4 and 6 months of age (usually given as DTPa-hepB-IPV-Hib). The birth dose hepatitis B vaccine is only scheduled for infants up to 7 days of age. If this dose was not given, a catch-up birth dose is not necessary. Where the birth dose was given, a further 3 doses of hepatitis B-containing vaccine are recommended (refer to 4.5 Hepatitis B). For all infants, the final dose of the primary hepatitis B vaccine course (with or without a birth dose) should preferably be administered at ≥24 weeks of age. However, if the final dose is given at <24 weeks but ≥16 weeks (approximately 4 months) of age, it is not necessary to repeat the dose (refer to Table 2.1.7).

In the circumstance where a child requires catch-up vaccination only for hepatitis B, but not any other components in the hepatitis B-containing combination vaccines, the standard schedule of monovalent hepatitis B vaccine (0, 1, 6 months) can be used for the remaining dose(s) if required (refer to 4.5 Hepatitis B), with minimum intervals as specified in Table 2.1.7.

In preterm (<32 weeks gestation) or low-birth-weight infants (<2000 g birth weight) it is recommended to give hepatitis B vaccine at birth, 2, 4 and 6 months of age, followed by either serological testing for anti-HBs or a hepatitis B booster dose at 12 months of age. 


**Conjugate meningococcal vaccines

The dose of all meningococcal conjugate vaccines (MenCCV, Hib-MenCCV, 4vMenCV) is 0.5 mL, to be given by IM injection.

Meningitec (MenCCV), Menjugate Syringe (MenCCV) and Menitorix (Hib-MenCCV) are registered for use from 6 weeks of age.

NeisVac-C (MenCCV) is registered for use from 8 weeks of age.

The recommended age for use of 4vMenCVs varies between vaccine brands. Menactra can be used from 2 years of age, Nimenrix from 12 months of age and Menveo from 2 months of age (refer to 4.10.13 Variations from product information).